From weight loss to muscle loss: rhabdomyolysis linked to semaglutide.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- From weight loss to muscle loss: rhabdomyolysis linked to semaglutide.
- Published In:
- Clinical kidney journal, 18(12), sfaf356 (2025)
- Authors:
- Jadvani, Rutvikkumar, Singh, Meenu
- Database ID:
- RPEP-11551
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-11551APA
Jadvani, Rutvikkumar; Singh, Meenu. (2025). From weight loss to muscle loss: rhabdomyolysis linked to semaglutide.. Clinical kidney journal, 18(12), sfaf356. https://doi.org/10.1093/ckj/sfaf356
MLA
Jadvani, Rutvikkumar, et al. "From weight loss to muscle loss: rhabdomyolysis linked to semaglutide.." Clinical kidney journal, 2025. https://doi.org/10.1093/ckj/sfaf356
RethinkPeptides
RethinkPeptides Research Database. "From weight loss to muscle loss: rhabdomyolysis linked to se..." RPEP-11551. Retrieved from https://rethinkpeptides.com/research/jadvani-2025-from-weight-loss-to
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.